Faltinemedix Signs 3-Year, $2.1M ODM Contract with UK's Crayo Medical
Predicted impact: Medium
ODM contract worth about $2.1M, roughly 18% of last year's revenue of ₩11.4B.
Finemedix파인메딕스
387570 · KOSDAQ · ₩387570 · 파인메딕스
₩5,860▼ ₩50 (0.85%)End-of-day · Oct 28, 2026 · End-of-day prices.
Price · 1Y −28.97%
- Market cap
- ₩33B
- Enterprise value
- ₩29B
- P/E
- —
- P/B
- 1.7×
- Dividend yield
- 0.0%
- ROE
- −3.1%
- Net margin
- −5.2%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−36.5% from the high
₩3,755Today: ₩5,650 – ₩6,000₩9,230
Returns
- 1W−3.9%
- 1M−6.5%
- 3M+44.7%
- 6M−20.5%
- YTD−21.9%
- 1Y−29.0%
- Volume today
- 4,049
- 0.6× the 20-day average
- Traded today
- ₩24M
- Listed shares
- 5,625,900
- EPS (12 months)
- −₩107
- Earnings yield −1.8%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 39 of 100 (50 is a normal day for this stock).
- SentimentMixedNews: Routine filing with no clear positive or negative news. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-7% over the last month; the price is below its 20-day average.
- News impactHigh3 news items and filings in two weeks; 1 rated high impact, 1 medium.
Signals describe activity, not recommendations. Not financial advice.
Finemedix stock overview
Finemedix (파인메딕스, KRX: 387570) is listed on KOSDAQ, in the Medical & precision devices sector. Fine Medics designs, manufactures and sells endoscopic instruments used in gastrointestinal procedures, including ESD and EMR knives, injectors, snares, biopsy forceps, ERCP tools, endoscopic ultrasound needles and hemostasis devices. Its shares closed at ₩5,860 on Oct 28, 2026, down 0.85% on the day, giving it a market value of ₩33B.
Key facts
- Market cap
- ₩33B
- Sector
- Medical & precision devices
- Latest price change
- −0.85%
- As of
- Oct 28, 2026
- Main business
- Fine Medics designs, manufactures and sells endoscopic instruments used in gastrointestinal procedures, including ESD and EMR knives, injectors, snares, biopsy forceps, ERCP tools, endoscopic ultrasound needles and hemostasis devices.
Quick answers about Finemedix
- What does Finemedix do?
- Fine Medics designs, manufactures and sells endoscopic instruments used in gastrointestinal procedures, including ESD and EMR knives, injectors, snares, biopsy forceps, ERCP tools, endoscopic ultrasound needles and hemostasis devices. Founded in 2009, it sells its products in South Korea and overseas, including Japan through an ODM agreement and Europe, and holds CE, FDA 510(K), MFDS, ISO 13485 and GMP certifications.
- What is the market cap of Finemedix?
- The market capitalisation of Finemedix was ₩33B at the close on Oct 28, 2026.
- Who are the largest shareholders of Finemedix?
- According to the latest official filings, the largest reported holders are Jeon Seong-woo (36.00%, as of Mar 31, 2025); Lee Mun-su (5.64%, as of Jun 26, 2026); Kim Sung-chul (3.16%, as of Dec 31, 2024).
- When is the next earnings report from Finemedix?
- Korean companies rarely announce results dates in advance. Based on when Finemedix filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
Fine Medics designs, manufactures and sells endoscopic instruments used in gastrointestinal procedures, including ESD and EMR knives, injectors, snares, biopsy forceps, ERCP tools, endoscopic ultrasound needles and hemostasis devices. Founded in 2009, it sells its products in South Korea and overseas, including Japan through an ODM agreement and Europe, and holds CE, FDA 510(K), MFDS, ISO 13485 and GMP certifications.
Written by AI from the company's latest annual report.
- Korean name
- 파인메딕스
- Themes
- Medical devices
- CEO
- 전성우
- Founded
- Jul 2009
- Listed
- Dec 2024
- Listed shares
- 5,625,900
- Fiscal year ends
- Month 12
- Website
- www.finemedix.com
Similar companies
- TSE131290 · ₩3T₩275,000+5.77%
- Kctech281820 · ₩1.9T₩95,500+3.92%
- Classys214150 · ₩1.8T₩27,000+1.89%
- Park Systems140860 · ₩1.6T₩229,500+1.77%
- DI003160 · ₩1.2T₩43,300+14.55%
- LivsMed491000 · ₩1.1T₩43,650+17.65%
- Curiox Biosystems445680 · ₩1.1T₩62,400+0.16%
- Seers458870 · ₩943B₩24,600−6.46%
Recent news
Pine Medix Signs ₩2.9B ODM Contract with UK's Crea Medical, Targeting US and Latin America
High impactPredicted impact: High
ODM contract worth about 25% of last year's revenue, well above the 10% threshold.
Recent filings
See all- Status Report on Acquisition Under Trust AgreementOct 26, 2026
- Half-year report (Jun 2026)Aug 13, 2026
- Buyback trust contract signedJul 22, 2026
- Amended: Annual report (Dec 2025)Jun 26, 2026
- 5%+ holding reportJun 26, 2026
Titles in Korean until English translations are added.
Also known as: Finemedix / 파인메딕스 / 387570 / KRX:387570
Source: KRX statistical information